论文部分内容阅读
本文报告了用新鲜胎肝无细胞悬液(NFLC)输注治疗再生障碍性贫血(再障)和化疗后的白血病.通过临床指标的分析和实验室验证NFLC中具有刺激CFU—G(粒系祖细胞)、BFU-E和CFU-E(红细祖细胞)生长的造血生长因子和提高机体非特异性免疫功能的作用.
This article reports the treatment of aplastic anemia (aplastic anemia) and chemotherapy-induced leukemia with fresh fetal liver cell-free suspension (NFLC) infusion.According to the analysis of clinical indicators and laboratory validation NFLC has the ability to stimulate CFU-G Progenitor cells), BFU-E and CFU-E (erythroid progenitor cells) and enhance the non-specific immune function of the body.